1. Home
  2. ADTX vs LICN Comparison

ADTX vs LICN Comparison

Compare ADTX & LICN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADTX
  • LICN
  • Stock Information
  • Founded
  • ADTX 2017
  • LICN 2004
  • Country
  • ADTX United States
  • LICN China
  • Employees
  • ADTX N/A
  • LICN N/A
  • Industry
  • ADTX Biotechnology: Pharmaceutical Preparations
  • LICN
  • Sector
  • ADTX Health Care
  • LICN
  • Exchange
  • ADTX Nasdaq
  • LICN Nasdaq
  • Market Cap
  • ADTX 3.1M
  • LICN 3.1M
  • IPO Year
  • ADTX 2020
  • LICN 2023
  • Fundamental
  • Price
  • ADTX $1.19
  • LICN $4.44
  • Analyst Decision
  • ADTX
  • LICN
  • Analyst Count
  • ADTX 0
  • LICN 0
  • Target Price
  • ADTX N/A
  • LICN N/A
  • AVG Volume (30 Days)
  • ADTX 2.0M
  • LICN 24.5K
  • Earning Date
  • ADTX 08-18-2025
  • LICN 01-01-0001
  • Dividend Yield
  • ADTX N/A
  • LICN N/A
  • EPS Growth
  • ADTX N/A
  • LICN N/A
  • EPS
  • ADTX N/A
  • LICN N/A
  • Revenue
  • ADTX $55,323.00
  • LICN $41,477,000.00
  • Revenue This Year
  • ADTX $15,768.94
  • LICN N/A
  • Revenue Next Year
  • ADTX N/A
  • LICN N/A
  • P/E Ratio
  • ADTX N/A
  • LICN N/A
  • Revenue Growth
  • ADTX N/A
  • LICN 4.32
  • 52 Week Low
  • ADTX $1.05
  • LICN $2.60
  • 52 Week High
  • ADTX $27,200.00
  • LICN $488.00
  • Technical
  • Relative Strength Index (RSI)
  • ADTX 38.91
  • LICN 53.94
  • Support Level
  • ADTX $1.05
  • LICN $4.02
  • Resistance Level
  • ADTX $1.35
  • LICN $4.41
  • Average True Range (ATR)
  • ADTX 0.20
  • LICN 0.25
  • MACD
  • ADTX 0.03
  • LICN 0.05
  • Stochastic Oscillator
  • ADTX 14.91
  • LICN 92.57

About ADTX Aditxt Inc.

Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics, the way bodies naturally induce tolerance to tissues.

About LICN Lichen China Limited

Lichen International Ltd is a financial and taxation service provider in China. The company provides financial and taxation solution services; education support services; and software and maintenance services in the PRC under its Lichen brand. The financial and taxation solution services comprise financial and taxation related management consultation, internal control management consultation, annual or regular consultation, and internal training and general consultation. The education support services comprise the provision of marketing, operational and technical support and the sales of teaching and learning materials. The software and maintenance services comprise the sales of financial and taxation analysis software and sales of financial and taxation training software.

Share on Social Networks: